Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca ADR announced earnings per share of $1.08 on revenue of $9.87B. Analysts polled by Investing.com anticipated EPS of $0.6238 on revenue of $9.49B.
AstraZeneca ADR shares are up 25.87% from the beginning of the year and are trading at $62.92 , down-from-52-week-high.They are outperforming the Nasdaq which is up 21.85% from the start of the year.
AstraZeneca ADR follows other major Healthcare sector earnings this month
AstraZeneca ADR's report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Pfizer had beat expectations on November 2 with third quarter EPS of $1.34 on revenue of $24.09B, compared to forecast for EPS of $1.08 on revenue of $22.58B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar